Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-24-040235

Options or other derivatives

  • Chief Business Officer acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Audet Juliette Berangere · Chief Business Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-04-01 Grant or award : show line 1 in the form Option (right to buy) +250,000 250,000 D
Loading xslF345X05/ownership.xml…